NGeniuS讓你感受前所未有的INGENIOUS。 自動化的未來式你跟上了嗎?

瞭解更多關於Biomek NGeniuS

若時間可轉換為等值貨幣 自動化移液處理系統便是能持續增值的黃金。

適用於次一代定序 (NGS) 工作流程的靈活自動化液體處理解決方案

Strike Workflow Gold



隆重介紹:新型Allegra V-15R桌上型離心機

瞭解更多關於Allegra V-15R

用科技與創新 將分選化繁為簡

瞭解更多關於CytoFLEX SRT

The Beckman Coulter Life Sciences Difference

Beckman Coulter's commitment to your research dates back to our origin in 1935. For more than 80 years, we have been a trusted partner for laboratory professionals, helping to advance scientific research and patient care. Beckman Coulter Life Sciences and is a global resource for millions of life science researchers, industrial and environmental technicians, and pharmaceutical and biomedical scientists.

Learn more

Latest news & updates

Press Release

Beckman Coulter Life Sciences Completes First Phase of Colorado Research and Development Hub with Grand Opening of $10 Million Loveland Offices

LOVELAND, CO – (January 19, 2023) – Beckman Coulter Life Sciences, a global leader in laboratory automation and innovation, further strengthens its commitment to the greater Loveland, Colorado community with the completion of the first phase of its new research and development hub.

Read more
Press Release

貝克曼庫爾特生命科學透過啟動 Biomek NGeniuS 次世代定序建庫系統 加速次世代定序

Indianapolis, IN – (June 28, 2022) 貝克曼庫爾特生命科學透過啟動 Biomek NGeniuS 次世代定序建庫系統強大的自動化功能,減少錯誤和手動操作時間,加速次世代定序。

Read more
Press Release

Beckman Coulter Life Sciences and Pillar Biosciences Sign Application Development Agreement for the Biomek NGeniuS System

INDIANAPOLIS – (October 31, 2022) – More companies around the world continue turning to Beckman Coulter Life Sciences, a global leader in laboratory automation and innovation, for their next generation sequencing (NGS) needs with the Biomek NGeniuS System. The company continues building a robust demonstrated application library as it announces an application development agreement with Pillar Biosciences, which specializes in developing and commercializing IVD & RUO NGS testing solutions that help research to optimize selection of precision therapies for cancer patients, from tumor profiling to therapy selection, and recurrence monitoring.  

Read more